The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Harvoni was produced by Bristol-Myers Squibb.
Epclusa joins Sovaldi and Harvoni (sofosbuvir/ledipasvir), a product specifically indicated for patients with hepatitis C virus genotype 1 infection, in Gilead's hep C portfolio. ... Sovaldi and Harvoni brought in sales of $5.3bn and $13.9bn respectively
In the last 4 years Gilead sales have grown from $8bn to $32bn (CAGR 40%), mainly driven by Sovaldi and Harvoni for hepatitis, resulting in a cash pile of over $20bn.
respectively. For Gilead, this is the first regulatory okay for Epclusa, a follow-up to its Sovaldi (sofosbuvir) and Harvoni (sofosbuvir/ledipasvir) products that currently dominate the HCV market with sales
Gilead's success with Sovaldi and Harvoni, whose total sales exceed $20bn, shows that a high price does not necessarily prevent market access.
Gilead's main product is Harvoni (sofosbuvir/ledipasvir), which made around $10bn in sales last year, and also sells sofosbuvir as a single-agent product (as Sovaldi) that added another ... discount to both Harvoni and Viekirax.
[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]
A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...